Keywords
Overexpression
Risk factors
HELLS
CEP55
FOXM1b
Submitted : 2024-08-19
Accepted : 2024-09-03
Published : 2024-09-18
Abstract
Skin cancer is a complex and serious health condition with high metastatic abilities and comprises two types including melanoma, the most dangerous type, and non-melanoma skin cancer, such as basal cell carcinoma and squamous cell carcinoma. Skin cancer has a high prevalence ratio and millions of mortalities worldwide. Multiple risk factors account for the initiation, development, progression, and metastasis of skin cancer such as ultraviolet radiations, X-rays, immunocompromised situations, skin lesions, and alteration in genetic makeup. CEP55, FOXM1b, and HELLS genes play critical roles in the progression of the cell cycle, cell proliferation, cell division, DNA replication, and repair system. The overexpression of these genes involves complex molecular mechanisms and is linked with the development and progression of multiple cancers including skin cancer. This review article summarized the history and recent advancement of risk factors for skin tumorigenesis development and progression.
References
Hofmann E, Schwarz, A, Fink, J, et al., 2023, Modelling the Complexity of Human Skin in vitro. Biomedicines, 11(3): 794.
Zwirner J, Hammer N, 2024, Anatomy and Physiology of the Skin, in Scars: A Practical Guide for Scar Therapy. Springer International Publishing, Cham, 3–9.
Vestita M, Tedeschi P, Bonamonte D, 2022, Anatomy and Physiology of the Skin, in Textbook of Plastic and Reconstructive Surgery: Basic Principles and New Perspectives. Springer International Publishing, Cham, 3–13.
Mohamed SA, Hargest R, 2022, Surgical Anatomy of the Skin. Surgery (Oxford), 40(1): 1–7.
Salazar J, Carmona T, Zacconi FC, 2022, The Human Dermis as a Target of Nanoparticles for Treating Skin Conditions. Pharmaceutics, 15(1): 10.
Liu M, Lu F, Feng J, 2024, Aging and Homeostasis of the Hypodermis in the Age-related Deterioration of Skin Function. Cell Death & Disease, 15(6): 443.
Alonso-Belmonte C, Montero-Vilchez T, Arias-Santiago S, et al., 2022, Current State of Skin Cancer Prevention: A Systematic Review. Actas dermo-sifiliograficas, 113(8): 781–791.
Szalay SD, Wertz PW, 2023, Protective Barriers Provided by the Epidermis. International Journal of Molecular Sciences, 24(4): 3145.
Murugan A, Nair SAH, Preethi AAP, et al., 2021, Diagnosis of Skin Cancer using Machine Learning Techniques. Microprocessors and Microsystems, 2021(81): 103727.
Conforti C, Zalaudek I, 2021, Epidemiology and Risk Factors of Melanoma: A Review. Dermatology Practical & Conceptual, 11(1): e2021161S.
Leiter U, Keim U, Garbe C, 2020, Epidemiology of Skin Cancer: Update 2019. Advances in Experimental Medicine and Biology, 2020(1268): 123–139.
Morgese F, Sampaolesi C, Torniai M, et al., 2020, Gender Differences and Outcomes in Melanoma Patients. Oncology and Therapy, 2020(8): 103–114.
Richard MA, Paul C, Nijsten T, et al., 2022, Prevalence of Most Common Skin Diseases in Europe: A Population-based Study. Journal of the European Academy of Dermatology and Venereology, 36(7): 1088–1096.
Nanz L, Keim U, Katalinic A, et al., 2024, Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma. Cancers, 16(3): 606.
Abubakar M, Bukhari SMA, Mustfa W, et al., 2024, Skin Cancer and Human Papillomavirus. Journal of Population Therapeutics and Clinical Pharmacology, 31(2): 790–816.
Narayanan DL, Saladi RN, Fox JL, 2010, Ultraviolet Radiation and Skin Cancer. International Journal of Dermatology, 49(9): 978–986.
Baba PUF, Hassan AU, Khurshid J, et al., 2024, Basal Cell Carcinoma: Diagnosis, Management and Prevention. Journal of Molecular Pathology, 5(2): 153–170.
Brunsgaard EK, Wu YP, Grossman D, 2023, Melanoma in Skin of Color: Part I. Epidemiology and Clinical Presentation. Journal of the American Academy of Dermatology, 89(3): 445–456.
Fijalkowska M, Koziej M, Antoszewski B, 2021, Detailed Head Localization and Incidence of Skin Cancers. Scientific Reports, 11(1): 12391.
Villani A, Potestio L, Lallas A, 2024, New Strategies for the Treatment of Advanced Melanoma and Non-melanoma Skin Cancer. Frontiers in Medicine, 2024(11): 1366008.
Khayyati KM, Sarkesh A, Mohamed KL, et al., 2023, Current Status of Skin Cancers with a Focus on Immunology and Immunotherapy. Cancer Cell International, 23(1): 174.
Darjania T, Kituashvili T, Galdava G, 2024, The Impact of Education Level on Basal Cell Carcinoma Development Risk. Cureus, 16(6): e61827.
Caudill J, Thomas JE, Burkhart CG, 2023, The Risk of Metastases from Squamous Cell Carcinoma of the Skin. International Journal of Dermatology, 62(4): 483–486.
Guo A, Liu X, Li H, et al., 2023, The Global, Regional, National Burden of Cutaneous Squamous Cell Carcinoma (1990–2019) and Predictions to 2035. European Journal of Cancer Care, 2023(1): 5484597.
Dzwierzynski WW, 2021, Melanoma Risk Factors and Prevention. Clinics in Plastic Surgery, 48(4): 543–550.
Ciazynska M, Kaminska-Winciorek G, Lange D, et al., 2021, The Incidence and Clinical Analysis of Non-melanoma Skin Cancer. Scientific Reports, 11(1): 4337.
Kliniec K, Tota M, Zalesinska A, et al., 2023, Skin Cancer Risk, Sun-Protection Knowledge and Behavior in Athletes—A Narrative Review. Cancers, 15(13): 3281.
Jones OT, Ranmuthu CK, Hall PN, et al., 2020, Recognising Skin Cancer in Primary Care. Advances in Therapy, 37(1): 603–616.
Pfeifer GP, 2020, Mechanisms of UV-induced Mutations and Skin Cancer. Genome Instability & Disease, 1(3): 99–113.
Okazaki R, 2022, Role of p53 in Regulating Radiation Responses. Life, 12(7): 1099.
Conforti C, Zalaudek I, 2021, Epidemiology and Risk Factors of Melanoma: A Review. Dermatology Practical & Conceptual, 11(1): e2021161S.
Hyeraci M, Papanikolau ES, Grimaldi M, et al., 2023, Systemic Photoprotection in Melanoma and Non-melanoma Skin Cancer. Biomolecules, 13(7): 1067.
Li X, Wang X, Shen T, et al., 2024, Advances in Photodynamic Therapy of Pathologic Scar. Photodiagnosis and Photodynamic Therapy, 2024(46): 104040.
Yardman-Frank JM, Fisher DE, 2021, Skin Pigmentation and its Control: From Ultraviolet Radiation to Stem Cells. Experimental Dermatology, 30(4): 560–571.
Moattari CR, Granstein RD, 2021, Neuropeptides and Neurohormones in Immune, Inflammatory and Cellular Responses to Ultraviolet Radiation. Acta Physiologica, 232(1): e13644.
Schwarz T, Schwarz A, 2021, Controllers of Cutaneous Regulatory T Cells: Ultraviolet Radiation and the Skin Microbiome. Biological Chemistry, 402(12): 1575–1581.
Tzanakakis G, Nikitovic D, 2022, Preface of the Special Issue on the Role of Extracellular Matrix in Development and Cancer Progression. Biomolecules, 12(3): 362.
Mayfosh AJ, Nguyen TK, Hulett MD, 2021, The Heparanase Regulatory Network in Health and Disease. International Journal of Molecular Sciences, 22(20): 11096.
Piperigkou Z, Kyriakopoulou K, Koutsakis C, 2021, Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer. Cancers, 13(6): 1441.
Yu L, Oh C, Shea CR, 2021, The Treatment of Non-melanoma Skin Cancer with Image-guided Superficial Radiation Therapy: An Analysis of 2917 Invasive and in situ Keratinocytic Carcinoma Lesions. Oncology and Therapy, 2021(9): 153–166.
Han H, Gade A, Ceci FM, et al., 2022, Superficial Radiation Therapy for Nonmelanoma Skin Cancer: A Review. Dermatological Reviews, 3(6): 409–417.
Sofinska K, Wilkosz N, Szymonski M, et al., 2020, Molecular Spectroscopic Markers of DNA Damage. Molecules, 25(3): 561.
Rehman B, Abubakar M, Kiani MN, et al., 2024, Analysis of Genetic Alterations in TP53 Gene in Breast Cancer: A Secondary Publication. Proceedings of Anticancer Research, 8(3): 25–35.
Hochheiser K, Gyorki DE, Gebhardt T, 2020, Skin Colonization with Beta Papilloma Virus Drives Tissue Immunity and Resistance to Squamous Cell Cancer. Immunology & Cell Biology, 98(1): 9–11.
Ina S, Lucia R, Carolina C, et al., 2021, Human Papillomavirus and Its Role in the Development of Cancer. In Human Viruses: Diseases, Treatments, and Vaccines: The New Insights. Springer International Publishing, Cham, 299–310.
Parvez R, Vijayachari P, Saha MK, et al., 2023, Distribution of Human Papillomavirus Genotypes among the Women of South Andaman Island, India. Diagnostics, 2023(13): 2765.
Woods RS, Callanan D, Jawad H, et al., 2022, Cytokeratin 7 and 19 Expression in Oropharyngeal and Oral Squamous Cell Carcinoma. European Archives of Oto-Rhino-Laryngology, 279(3): 1435–1443.
Stoev L, Stoeva M, Tzaneva M, 2021, Tetraspanin 151 and its Role in Carcinogenesis. Varna Medical Forum, 10(2): 111–117.
Rollan MP, Cabrera R, Schwartz RA, 2022, Current Knowledge of Immunosuppression as a Risk Factor for Skin Cancer Development. Critical Reviews in Oncology/Hematology, 2022(177): 103754.
Bakker D, Bakker WJ, Bekkenk MW, et al., 2023, Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients. Cells, 12(20): 2441.
Rollan MP, Cabrera R, Schwartz RA, 2022, Current Knowledge of Immunosuppression as a Risk Factor for Skin Cancer Development. Critical Reviews in Oncology/Hematology, 2022(177): 103754.
Gjersvik P, Falk RS, Roscher I, et al., 2023, Rates of Second Tumor, Metastasis, and Death from Cutaneous Squamous Cell Carcinoma in Patients with and without Transplant-associated Immunosuppression. JAMA dermatology, 159(9): 923–929.
Correa-Lara MV, Lara-Vega I, Najera-Martinez M, et al., 2023, Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 are Induced by Pentoxifylline, Norcantharidin, and their Mixtures for Killing Murine Melanoma Cells. Pharmaceuticals, 16(10): 1472.
Meyer T, Stockfleth E, 2021, Light and Skin. Challenges in Sun Protection, 2021(55): 53–61.
Contursi A, Tacconelli S, Hofling U, et al., 2022, Biology and Pharmacology of Platelet-type 12-lipoxygenase in Platelets, Cancer Cells, and their Crosstalk. Biochemical Pharmacology, 2022(205): 115252.
Salminen A, Kaarniranta K, Kauppinen A, 2022, Photoaging: UV Radiation-induced Inflammation and Immunosuppression Accelerate the Aging Process in the Skin. Inflammation Research, 71(7): 817–831.
Khayyati KM, Sarkesh A, Mohamed KL, 2023, Current Status of Skin Cancers with a Focus on Immunology and Immunotherapy. Cancer Cell International, 23(1): 174.
Ramakrishnan R, Mohammed MA, Mohammed MA, et al., 2023, An Innovation Prediction of DNA Damage of Melanoma Skin Cancer Patients using Deep Learning. 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), 1–7.
King C, Fowler JC, Abnizova I, 2023, Somatic Mutations in Facial Skin from Countries of Contrasting Skin Cancer Risk. Nature Genetics, 55(9): 1440–1447.
Bahmad HF, Oh KS, Alexis J, 2023, Potential Diagnostic Utility of PRAME and P16 Immunohistochemistry in Melanocytic Nevi and Malignant Melanoma. Journal of Cutaneous Pathology, 50(8): 763–772.
Zhang X, Xu Q, Li E, et al., 2023, CEP55 Predicts the Poor Prognosis and Promotes Tumorigenesis in Endometrial Cancer by Regulating the Foxo1 Signaling. Molecular and Cellular Biochemistry, 478(7): 1561–1571.
Huang M, Zhong F, Chen M, et al., 2023, CEP55 as a Promising Biomarker and Therapeutic Target on Gallbladder Cancer. Frontiers in Oncology, 2023(13): 1156177.
Wangmo D, Gates TJ, Zhao X, et al., 2024, Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer. Vaccines, 12(1): 63.
Li GS, Zhang W, Huang WY, et al., 2023, CEP55: An Immune-related Predictive and Prognostic Molecular Biomarker for Multiple Cancers. BMC Pulmonary Medicine, 23(1): 166.
Wang G, Chen B, Su Y, et al., 2023, CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification. Cells, 12(20): 2457.
Tang Y, Thiess L, Weiler SM, et al., 2023, a-catenin Interaction with YAP/FoxM1/TEAD-induced CEP55 Supports Liver Cancer Cell Migration. Cell Communication and Signaling, 21(1): 162.
Khan MA, Khan P, Ahmad A, et al., 2023, FOXM1: A Small Fox that Makes more Tracks for Cancer Progression and Metastasis. Seminars in Cancer Biology, 2023(92): 1–15.
Zhang Z, Liu W, Bao X, Sun T, et al., 2022, USP39 Facilitates Breast Cancer Cell Proliferation through Stabilization of FOXM1. American Journal of Cancer Research, 12(8): 3644.
Katzenellenbogen BS, Guillen VS, Katzenellenbogen JA, 2023, Targeting the Oncogenic Transcription Factor FOXM1 to Improve Outcomes in all Subtypes of Breast Cancer. Breast Cancer Research, 25(1): 76.
Higurashi M, Maruyama T, Nogami Y, et al., 2020, High Expression of FOXM1 Critical for Sustaining Cell Proliferation in Mitochondrial DNA-less Liver Cancer Cells. Experimental Cell Research, 389(1): 111889.
Kalathil D, John S, Nair AS, 2021, FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis. Frontiers in Oncology, 2021(10): 626836.
Liu C, Barger CJ, Karpf AR, 2021, FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer. Cancers, 13(12): 3065.
Phongkitkarun K, Chusorn P, Kamkaew M, et al., 2023, Chemically Tunable FOXM1-D Sensor Revealed FOXM1 Direct Influence on Cell Cycle. bioRxiv, 530713.
Chand V, Liao X, Guzman G, et al., 2022, Hepatocellular Carcinoma Evades RB1-induced Senescence by Activating the FOXM1–FOXO1 Axis. Oncogene, 41(30): 3778–3790.
Pan F, Chocarro S, Ramos M, et al., 2023, FOXM1 is Critical for the Fitness Recovery of Chromosomally Unstable Cells. Cell Death & Disease, 14(7): 430.
Nandi I, Smith HW, Sanguin-Gendreau V, et al., 2023, Coordinated Activation of c-Src and FOXM1 drives Tumor Cell Proliferation and Breast Cancer Progression. The Journal of Clinical Investigation, 133(7): e162324.
Kopanja D, Chand V, O’Brien E, et al., 2022, Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer. Cancer Research, 82(13): 2458–2471.
Choi YE, Madhi H, Kim H, 2020, FAM188B Expression is Critical for Cell Growth via FOXM1 Regulation in Lung Cancer. Biomedicines, 8(11): 465.
Li C, Qi Y, Chen C, et al., 2024, The Prognostic Significance of FoxM1 and its Immune Regulatory Function in Liver Hepatocellular Carcinoma. Preprint. https://doi.org/10.21203/rs.3.rs-3955595/v1
Alimardan Z, Abbasi M, Hasanzadeh F, et al., 2023, Heat Shock Proteins and Cancer: The FoxM1 Connection. Biochemical Pharmacology, 2023(211): 115505.
García-Sánchez D, González-González A, Alfonso-Fernández A, 2023, Communication between Bone Marrow Mesenchymal Stem Cells and Multiple Myeloma cells: Impact on Disease Progression. World Journal of Stem Cells, 15(5): 421.
Kumar S, Ziegler Y, Plotner BN, et al., 2024, Resistance to FOXM1 Inhibitors in Breast Cancer is Accompanied by Impeding Ferroptosis and Apoptotic Cell Death. Breast Cancer Research and Treatment, 1–14. https://doi.org/10.1007/s10549-024-07420-9
Yao H, Li J, Zhou D, et al., 2024, FOXM1 Transcriptional Regulation of RacGAP1 Activates the PI3K/AKT Signaling Pathway to Promote the Proliferation, Migration, and Invasion of Cervical Cancer Cells. International Journal of Clinical Oncology, 29(3): 333–344.
Lee W, Song G, Bae H, 2023, Glucotropaeolin Promotes Apoptosis by Calcium Dysregulation and Attenuates Cell Migration with FOXM1 Suppression in Pancreatic Cancer Cells. Antioxidants, 12(2): 257.
Bai J, Li Y, Cai L, 2023, Clinical Implications of Forkhead Box M1, Cyclooxygenase-2, and Glucose-regulated Protein 78 in Breast Invasive Ductal Carcinoma. World Journal of Clinical Cases, 11(30): 7284.
Jain SM, Deka D, Das A, et al., 2023, Role of Interleukins in Inflammation-mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis. Digestive Diseases and Sciences, 68(8): 3220–3236.
Tameni A, Mallia S, Manicardi V, et al., 2024, HELLS Regulates Transcription in T-cell Lymphomas by Reducing Unscheduled R-loops and by Facilitating RNAPII Progression. Nucleic Acids Research, 52(11): 6171–6182.
Nie S, Lou L, Wang J, et al., 2020, Expression, Association with Clinicopathological Features and Prognostic Potential of CEP55, p Akt, FoxM1 and MMP 2 in Astrocytoma. Oncology Letters, 20(2): 1685–1694.
Tandon D, Banerjee, M, 2020, Centrosomal Protein 55: A New Paradigm in Tumorigenesis. European Journal of Cell Biology, 99(5): 151086.
Peixoto E, Khan A, Lewis ZA, et al., 2022, The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer. International Journal of Molecular Sciences, 23(16): 9313.
Schuller S, Sieker J, Riemenschneider P, et al., 2022, HELLS is Negatively Regulated by Wild-type P53 in Liver Cancer by a Mechanism involving P21 and FOXM1. Cancers, 14(2): 459.
Yadav RP, Leskinen S, Ma L, et al., 2023, Chromatin Remodelers HELLS, WDHD1, and BAZ1A are Dynamically Expressed during Mouse Spermatogenesis. Reproduction, 165(1): 49–63.
Gong Y, Liu Y, 2023, R-loops at Chromosome Ends: from Formation, Regulation, and Cellular Consequence. Cancers, 15(7): 2178.
Jaff SR, 2023, Identification of Regions Required for CDCA7 Interaction with DNA Damage Repair Machinery, thesis, York University.
Wassing IE, Nishiyama A, Hiruta M, et al., 2023, CDCA7 is a Hemimethylated DNA Adaptor for the Nucleosome Remodeler HELLS. bioRxiv. https://doi.org/10.1101/2023.12.19.572350
Furukawa T, Mimami K, Nagata T, et al., 2023, Approach to Functions of BHLHE41/DEC2 in non-small Lung Cancer Development. International Journal of Molecular Sciences, 24(14): 11731.
Kumari R, Hummerich H, Shen X, et al., 2021, Simultaneous Expression of MMB-FOXM1 Complex Components Enables Efficient Bypass of Senescence. Scientific Reports, 11(1): 21506.
Zhang T, Zhao Y, Zhao Y, et al., 2020, Expression and Prognosis Analysis of TET Family in Acute Myeloid Leukemia. Aging (Albany NY), 12(6): 5031.